Streetbeat News

Earnings

EMKR

EMCORE (NASDAQ:EMKR) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $-0.13. The company's past performance shows a trend of missing EPS estimates and subsequent drops in share price. Shares of EMCORE were trading at $0.6602 as of August 04, with a 52-week period decline of 79.49%.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 7:01 pm

THRN

Thorne HealthTech (NASDAQ:THRN) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an EPS of $0.06. The company's past performance shows a pattern of share price changes following earnings reports. The stock is currently trading at $5.87, down 2.62% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 7:01 pm

SYRS

Syros Pharmaceuticals (NASDAQ:SYRS) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $-1.13. The company's past performance shows a pattern of share price changes following earnings reports. The stock is currently trading at $3.65, down 61.07% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 7:01 pm

AVIR

Atea Pharmaceuticals (NASDAQ:AVIR) is set to release its latest quarterly earnings report on August 8, 2023. Analysts estimate an earnings per share (EPS) of $-0.47. The company's past performance shows a trend of beating EPS estimates but experiencing a drop in share price. The stock is currently trading at $3.47, down 59.96% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 7:01 pm

BNTX

MRNA

Moderna, Inc. (NASDAQ:MRNA) shares traded lower on Monday, possibly in sympathy with BioNTech (NASDAQ:BNTX), which reported a year-over-year drop in sales and reduced its R&D spending outlook for 2023. BioNTech's Q2 sales were €167.70 million ($207.94 million), a 94.75% decrease from the same period last year. Moderna's shares fell nearly 7% in response to BioNTech's earnings report.

Portfolio Pulse from Ryan Gustafson

August 07, 2023 | 7:00 pm

NVDA

BofA Securities analyst Vivek Arya reiterated a Buy rating on Nvidia Corp (NASDAQ:NVDA) with a price target of $550. Arya expects Nvidia's 2Q sales to be inline/modestly ahead better than guide $11 billion (+64% YoY), including around $7.8 billion -8 billion in data center. He also expects 3Q sales to accelerate to up +100% YoY towards $12 billion - $12.5 billion. Arya estimates a gross margin of 70% with an upside if the data center mix increases. He also forecasts AI servers to grow at a 37% CAGR from 1.23 million in CY23 towards 4.4 million by CY27E, enabling Nvidia's total sales to expand at a 26% CAGR to $109 billion.

Portfolio Pulse from Anusuya Lahiri

August 07, 2023 | 6:50 pm

ACMR

ACM Research Inc (NASDAQ:ACMR) has been reiterated with a Buy rating by Benchmark and Needham analysts, with price targets of $32 and $18 respectively. The company posted strong 2Q23 results and maintained its sales guidance range of $515 million - $585 million for the year. The firm is expanding its customer base in the U.S. and Europe and is gaining market traction. It is also on track with international expansion and is acquiring land for a new R&D and production center to serve the Korean market better.

Portfolio Pulse from Anusuya Lahiri

August 07, 2023 | 6:43 pm

HSIC

SAGE

SQNS

TIVC

TRHC

VTGN

YELL

US stocks traded higher with the Dow Jones gaining more than 350 points. Henry Schein Inc reported better-than-expected Q2 earnings but slightly missed sales consensus. Vistagen Therapeutics, Tabula Rasa HealthCare, and Sequans Communications saw their shares rise after positive news. Sage Therapeutics, Tivic Health Systems, and Yellow Corporation saw their shares drop due to negative developments.

Portfolio Pulse from Lisa Levin

August 07, 2023 | 6:30 pm

PARA

An option alert has been issued for Paramount Global, with 1250 calls at the ask price of $1.81 for January 19th, $17.5. This is compared to an open interest of 11740. The company's earnings will be announced after close on August 7th. The reference price is $16.005.

Portfolio Pulse from Charles Gross

August 07, 2023 | 6:22 pm

AMZN

SSNLF

WMT

XIACY

Amazon.com, Inc. (NASDAQ:AMZN) continues to attract investor attention with positive Q2 results and exclusive deals for the Amazon Great Freedom Sale 2023 in India. The company announced deals for Samsung Electronics Co, Ltd (OTC:SSNLF), Xiaomi Corp (OTC: XIACY), and others. Amazon plans to increase its investments in India to $26 billion by 2030. The company's Q2 revenue increased 11% YoY to $134.4 billion, beating estimates. Amazon also plans to merge its various e-commerce supermarket offerings to compete with Walmart Inc (NYSE:WMT).

Portfolio Pulse from Anusuya Lahiri

August 07, 2023 | 6:06 pm